This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Joseph, A. M.
Right arrow Articles by Thorley-Lawson, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Joseph, A. M.
Right arrow Articles by Thorley-Lawson, D. A.

 Previous Article  |  Next Article 

Journal of Virology, November 2000, p. 9964-9971, Vol. 74, No. 21
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Cells Expressing the Epstein-Barr Virus Growth Program Are Present in and Restricted to the Naive B-Cell Subset of Healthy Tonsils

Alexandra M. Joseph, Gregory J. Babcock, and David A. Thorley-Lawson*

Department of Pathology, Tufts University School of Medicine, Boston, Massachusetts 02111

Received 5 May 2000/Accepted 8 August 2000

In this paper we demonstrate, for the first time, that Epstein-Barr virus (EBV)-infected cells expressing the lymphoblastoid growth program are present in healthy carriers of the virus. Previously we observed that latently infected naive B cells are present in tonsils only when viral replication is detected, suggesting that these may represent newly infected B cells. We have tested this idea by performing a reverse transcription-PCR analysis for the expression of latent genes (EBNA2 and the EBNA3s) that are characteristically expressed only by newly infected cells expressing the growth latency program. EBNA2 expression is regularly detected in purified naive (IgD+) tonsillar B cells (13 of 16 tonsils tested) but was never found in the IgD- population (0 of 16). More detailed analysis revealed that the mRNAs for the latent genes EBNA1 (3 of 3 tonsils tested), EBNA3a (3 of 5), EBNA3b (3 of 5), EBNA3c (3 of 5), LMP1 (6 of 6), and LMP2 (5 of 6) were also present in the IgD+ population, but the EBNA1Q-K transcript, characteristic of nonlymphoblastoid forms of latency, was never detected (0 of 6). Finally, we demonstrate that the latently infected naive (IgD+) cells express CD80 (B7.1), a marker characteristically expressed on activated naive lymphoblasts but absent from resting naive B cells. The infected naive (IgD+) population in the tonsil therefore has the viral and cellular phenotype of a B-cell directly infected with EBV---an activated lymphoblast expressing the growth program.

* Corresponding author. Mailing address: Dept. of Pathology, Tufts University School of Medicine, 136 Harrison Ave., Boston, MA 02111. Phone: (617) 636-2726. Fax: (617) 636-2990. E-mail: dlawson{at}opal.tufts.edu.

Journal of Virology, November 2000, p. 9964-9971, Vol. 74, No. 21
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Chaganti, S., Heath, E. M., Bergler, W., Kuo, M., Buettner, M., Niedobitek, G., Rickinson, A. B., Bell, A. I. (2009). Epstein-Barr virus colonization of tonsillar and peripheral blood B-cell subsets in primary infection and persistence. Blood 113: 6372-6381 [Abstract] [Full Text]  
  • Rovedo, M., Longnecker, R. (2008). Epstein-Barr Virus Latent Membrane Protein 2A Preferentially Signals through the Src Family Kinase Lyn. J. Virol. 82: 8520-8528 [Abstract] [Full Text]  
  • Chaganti, S., Ma, C. S., Bell, A. I., Croom-Carter, D., Hislop, A. D., Tangye, S. G., Rickinson, A. B. (2008). Epstein-Barr virus persistence in the absence of conventional memory B cells: IgM+IgD+CD27+ B cells harbor the virus in X-linked lymphoproliferative disease patients. Blood 112: 672-679 [Abstract] [Full Text]  
  • Yin, Q., McBride, J., Fewell, C., Lacey, M., Wang, X., Lin, Z., Cameron, J., Flemington, E. K. (2008). MicroRNA-155 Is an Epstein-Barr Virus-Induced Gene That Modulates Epstein-Barr Virus-Regulated Gene Expression Pathways. J. Virol. 82: 5295-5306 [Abstract] [Full Text]  
  • Dorner, M., Zucol, F., Berger, C., Byland, R., Melroe, G. T., Bernasconi, M., Speck, R. F., Nadal, D. (2008). Distinct Ex Vivo Susceptibility of B-Cell Subsets to Epstein-Barr Virus Infection According to Differentiation Status and Tissue Origin. J. Virol. 82: 4400-4412 [Abstract] [Full Text]  
  • Yin, Q., Wang, X., McBride, J., Fewell, C., Flemington, E. (2008). B-cell Receptor Activation Induces BIC/miR-155 Expression through a Conserved AP-1 Element. J. Biol. Chem. 283: 2654-2662 [Abstract] [Full Text]  
  • Bhaduri-McIntosh, S., Rotenberg, M. J., Gardner, B., Robert, M., Miller, G. (2008). Repertoire and frequency of immune cells reactive to Epstein-Barr virus-derived autologous lymphoblastoid cell lines. Blood 111: 1334-1343 [Abstract] [Full Text]  
  • Martin, H. J., Lee, J. M., Walls, D., Hayward, S. D. (2007). Manipulation of the Toll-Like Receptor 7 Signaling Pathway by Epstein-Barr Virus. J. Virol. 81: 9748-9758 [Abstract] [Full Text]  
  • Tierney, R., Nagra, J., Hutchings, I., Shannon-Lowe, C., Altmann, M., Hammerschmidt, W., Rickinson, A., Bell, A. (2007). Epstein-Barr Virus Exploits BSAP/Pax5 To Achieve the B-Cell Specificity of Its Growth-Transforming Program. J. Virol. 81: 10092-10100 [Abstract] [Full Text]  
  • MacArthur, G. J., Wilson, A. D., Birchall, M. A., Morgan, A. J. (2007). Primary CD4+ T-Cell Responses Provide both Helper and Cytotoxic Functions during Epstein-Barr Virus Infection and Transformation of Fetal Cord Blood B Cells. J. Virol. 81: 4766-4775 [Abstract] [Full Text]  
  • Kim, I.-J., Burkum, C. E., Cookenham, T., Schwartzberg, P. L., Woodland, D. L., Blackman, M. A. (2007). Perturbation of B Cell Activation in SLAM-Associated Protein-Deficient Mice Is Associated with Changes in Gammaherpesvirus Latency Reservoirs. J. Immunol. 178: 1692-1701 [Abstract] [Full Text]  
  • Pappworth, I. Y., Wang, E. C., Rowe, M. (2007). The Switch from Latent to Productive Infection in Epstein-Barr Virus-Infected B Cells Is Associated with Sensitization to NK Cell Killing. J. Virol. 81: 474-482 [Abstract] [Full Text]  
  • Rovedo, M., Longnecker, R. (2007). Epstein-Barr Virus Latent Membrane Protein 2B (LMP2B) Modulates LMP2A Activity. J. Virol. 81: 84-94 [Abstract] [Full Text]  
  • Le Clorennec, C., Youlyouz-Marfak, I., Adriaenssens, E., Coll, J., Bornkamm, G. W., Feuillard, J. (2006). EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-{kappa}B, STAT1, and p53. Blood 107: 2070-2078 [Abstract] [Full Text]  
  • Conacher, M., Callard, R., McAulay, K., Chapel, H., Webster, D., Kumararatne, D., Chandra, A., Spickett, G., Hopwood, P. A., Crawford, D. H. (2005). Epstein-Barr Virus Can Establish Infection in the Absence of a Classical Memory B-Cell Population. J. Virol. 79: 11128-11134 [Abstract] [Full Text]  
  • Moser, J. M., Upton, J. W., Allen, R. D. III, Wilson, C. B., Speck, S. H. (2005). Role of B-Cell Proliferation in the Establishment of Gammaherpesvirus Latency. J. Virol. 79: 9480-9491 [Abstract] [Full Text]  
  • Gross, A. J., Hochberg, D., Rand, W. M., Thorley-Lawson, D. A. (2005). EBV and Systemic Lupus Erythematosus: A New Perspective. J. Immunol. 174: 6599-6607 [Abstract] [Full Text]  
  • Willer, D. O., Speck, S. H. (2005). Establishment and Maintenance of Long-Term Murine Gammaherpesvirus 68 Latency in B Cells in the Absence of CD40. J. Virol. 79: 2891-2899 [Abstract] [Full Text]  
  • Pages, F., Galon, J., Karaschuk, G., Dudziak, D., Camus, M., Lazar, V., Camilleri-Broet, S., Lagorce-Pages, C., Lebel-Binay, S., Laux, G., Fridman, W.-H., Henglein, B. (2005). Epstein-Barr virus nuclear antigen 2 induces interleukin-18 receptor expression in B cells. Blood 105: 1632-1639 [Abstract] [Full Text]  
  • Hochberg, D., Souza, T., Catalina, M., Sullivan, J. L., Luzuriaga, K., Thorley-Lawson, D. A. (2004). Acute Infection with Epstein-Barr Virus Targets and Overwhelms the Peripheral Memory B-Cell Compartment with Resting, Latently Infected Cells. J. Virol. 78: 5194-5204 [Abstract] [Full Text]  
  • Farrell, C. J., Lee, J. M., Shin, E.-C., Cebrat, M., Cole, P. A., Hayward, S. D. (2004). Inhibition of Epstein-Barr virus-induced growth proliferation by a nuclear antigen EBNA2-TAT peptide. Proc. Natl. Acad. Sci. USA 101: 4625-4630 [Abstract] [Full Text]  
  • Thorley-Lawson, D. A., Gross, A. (2004). Persistence of the Epstein-Barr Virus and the Origins of Associated Lymphomas. NEJM 350: 1328-1337 [Full Text]  
  • Nakayama, T., Hieshima, K., Nagakubo, D., Sato, E., Nakayama, M., Kawa, K., Yoshie, O. (2004). Selective Induction of Th2-Attracting Chemokines CCL17 and CCL22 in Human B Cells by Latent Membrane Protein 1 of Epstein-Barr Virus. J. Virol. 78: 1665-1674 [Abstract] [Full Text]  
  • He, B., Raab-Traub, N., Casali, P., Cerutti, A. (2003). EBV-Encoded Latent Membrane Protein 1 Cooperates with BAFF/BLyS and APRIL to Induce T Cell-Independent Ig Heavy Chain Class Switching. J. Immunol. 171: 5215-5224 [Abstract] [Full Text]  
  • Flano, E., Kim, I.-J., Moore, J., Woodland, D. L., Blackman, M. A. (2003). Differential {gamma}-Herpesvirus Distribution in Distinct Anatomical Locations and Cell Subsets During Persistent Infection in Mice. J. Immunol. 170: 3828-3834 [Abstract] [Full Text]  
  • Flano, E., Kim, I.-J., Woodland, D. L., Blackman, M. A. (2002). {gamma}-Herpesvirus Latency Is Preferentially Maintained in Splenic Germinal Center and Memory B Cells. JEM 196: 1363-1372 [Abstract] [Full Text]  
  • Keating, S., Prince, S., Jones, M., Rowe, M. (2002). The Lytic Cycle of Epstein-Barr Virus Is Associated with Decreased Expression of Cell Surface Major Histocompatibility Complex Class I and Class II Molecules. J. Virol. 76: 8179-8188 [Abstract] [Full Text]  
  • Clambey, E. T., Virgin, H. W. IV, Speck, S. H. (2002). Characterization of a Spontaneous 9.5-Kilobase-Deletion Mutant of Murine Gammaherpesvirus 68 Reveals Tissue-Specific Genetic Requirements for Latency. J. Virol. 76: 6532-6544 [Abstract] [Full Text]  
  • Tune, C. E., Pilon, M., Saiki, Y., Dosch, H.-M. (2002). Sustained Expression of the Novel EBV-Induced Zinc Finger Gene, ZNFEB, Is Critical for the Transition of B Lymphocyte Activation to Oncogenic Growth Transformation. J. Immunol. 168: 680-688 [Abstract] [Full Text]  
  • Harris, R. S., Croom-Carter, D. S. G., Rickinson, A. B., Neuberger, M. S. (2001). Epstein-Barr Virus and the Somatic Hypermutation of Immunoglobulin Genes in Burkitt's Lymphoma Cells. J. Virol. 75: 10488-10492 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»